Recent Posts on This Topic | See All >
Michigan's Van Andel Institute set to open expanded facility, triple staffTags: cancer, diabetes, neuroscience, tgen
[Source: GenomeWeb News] – Van Andel Institute next week will formally open its $178 million Phase II research-education project, an expansion of its Grand Rapids, Mich., facility that will nearly triple its laboratory space, allowing it to expand its research and more than triple its staff.
The institute will mark the project's completion with a Dec. 8 ribbon-cutting. Van Andel will use the eight-story, 240,000-square-foot Phase II facility to house expanded research space for neurological disorders such as Parkinson's disease, Alzheimer's disease, ALS, and multiple sclerosis, in addition to chronic illnesses such as diabetes through an affiliation with the Translational Genomics Research Institute in Phoenix.
For more information: Van Andel Set to Open Expanded Facility, Triple Staff
Now available: “Arizona’s Bioscience Roadmap 2014-2025: Advancing the Biosciences and Improving Health Outcomes,” is now available along with its supplement, “Summary of Goals, Strategies, and Potential Actions.” An overview by Walter Plosila, Ph.D., Battelle senior advisor, is also available. The updated Roadmap provides a long-term strategy for Arizona to achieve bioscience success over the next decade.